Public Equity Portfolio News: Cerevel Therapeutics and Arya Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development
July 30, 2020 07:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Cerevel Therapeutics, Inc. (“Cerevel Therapeutics”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Arya…